• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941820220
Medical Device Problem Code Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/22/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that stent damage occurred.The 75% stenosed target lesion was located in the moderately tortuous and severely calcified diagonal artery.A 2.25 x 20mm synergy xd drug-eluting stent was advanced for treatment but failed to cross the lesion.The device was removed and one of the struts on the distal end of the stent was found to be bent.The procedure was completed with no patient complications reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: the synergy xd mr us 2.25 x 20mm stent delivery system was returned for analysis.A visual examination of the stent found evidence of damage with struts on the proximal end in a lifted state.The undamaged crimped stent outer diameter was measuredand was within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube found multiple kinks.A visual examination of the outer and inner lumen and mid-shaft section found no issues along the shaft polymer extrusion.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that stent damage occurred.The 75% stenosed target lesion was located in the moderately tortuous and severely calcified diagonal artery.A 2.25 x 20mm synergy xd drug-eluting stent was advanced for treatment but failed to cross the lesion.The device was removed and one of the struts on the distal end of the stent was found to be bent.The procedure was completed with no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key12256109
Report Number2134265-2021-09839
Device Sequence Number19850230
Product Code NIQ
UDI-Device Identifier08714729980735
UDI-Public08714729980735
Combination Product (Y/N)Y
Initial Reporter StateOH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/09/2023
Device Model NumberH7493941820220
Device Lot Number0027006780
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2021
Initial Date Received by Manufacturer 07/22/2021
Supplement Date Received by Manufacturer08/25/2021
Initial Report FDA Received Date07/30/2021
Supplement Report FDA Received Date09/01/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-